LAVIOLA, Luigi
 Distribuzione geografica
Continente #
NA - Nord America 13.064
AS - Asia 5.785
EU - Europa 4.100
SA - Sud America 1.477
AF - Africa 254
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 24.696
Nazione #
US - Stati Uniti d'America 12.859
SG - Singapore 2.415
CN - Cina 1.421
BR - Brasile 1.165
IT - Italia 872
SE - Svezia 674
HK - Hong Kong 631
RU - Federazione Russa 520
DE - Germania 410
VN - Vietnam 390
FR - Francia 347
FI - Finlandia 346
UA - Ucraina 295
GB - Regno Unito 282
IN - India 224
AR - Argentina 112
BD - Bangladesh 102
CA - Canada 93
ID - Indonesia 83
IQ - Iraq 82
MX - Messico 70
CI - Costa d'Avorio 68
NL - Olanda 67
PK - Pakistan 57
TR - Turchia 57
JP - Giappone 52
BE - Belgio 48
EC - Ecuador 48
ZA - Sudafrica 46
ES - Italia 42
PL - Polonia 42
CO - Colombia 39
VE - Venezuela 37
IE - Irlanda 36
SA - Arabia Saudita 36
UZ - Uzbekistan 34
AT - Austria 30
MA - Marocco 30
MY - Malesia 29
PH - Filippine 26
CL - Cile 24
PE - Perù 24
EG - Egitto 21
TN - Tunisia 21
JO - Giordania 20
KE - Kenya 16
IL - Israele 15
LT - Lituania 14
CZ - Repubblica Ceca 13
PY - Paraguay 13
JM - Giamaica 12
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
NP - Nepal 11
AZ - Azerbaigian 10
KG - Kirghizistan 10
AU - Australia 9
GR - Grecia 9
PA - Panama 9
KZ - Kazakistan 8
OM - Oman 8
BO - Bolivia 7
CH - Svizzera 7
KR - Corea 7
LB - Libano 7
AL - Albania 6
BY - Bielorussia 6
ET - Etiopia 6
IR - Iran 6
SY - Repubblica araba siriana 6
AM - Armenia 5
HU - Ungheria 5
LY - Libia 5
NG - Nigeria 5
SN - Senegal 5
GY - Guiana 4
HR - Croazia 4
PS - Palestinian Territory 4
RO - Romania 4
DO - Repubblica Dominicana 3
GH - Ghana 3
GT - Guatemala 3
HN - Honduras 3
QA - Qatar 3
RS - Serbia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
EU - Europa 2
GE - Georgia 2
KW - Kuwait 2
MD - Moldavia 2
MG - Madagascar 2
Totale 24.657
Città #
Ashburn 1.434
Singapore 1.339
Fairfield 1.221
Chandler 978
Woodbridge 974
San Jose 759
Houston 685
Jacksonville 672
Hong Kong 626
Nyköping 527
Cambridge 493
Ann Arbor 474
Seattle 467
Beijing 382
Wilmington 362
Dearborn 343
New York 237
Bari 219
Roxbury 214
Lauterbourg 211
Lawrence 204
Nanjing 202
Los Angeles 199
Helsinki 172
Boardman 145
Des Moines 139
Dallas 128
Ho Chi Minh City 127
São Paulo 101
Inglewood 96
Council Bluffs 86
Princeton 82
Brooklyn 81
Hanoi 79
Santa Clara 77
Munich 76
San Diego 69
Abidjan 68
Buffalo 68
London 64
Hebei 55
Nanchang 51
Orem 51
Jiaxing 50
Rio de Janeiro 50
Shenyang 50
Brussels 47
Falkenstein 47
Moscow 45
Jakarta 44
Hefei 43
Frankfurt am Main 42
Tokyo 41
Paris 38
Baghdad 37
Chennai 37
Belo Horizonte 36
Tianjin 35
Montreal 34
Guangzhou 33
Dublin 32
Pune 32
Amsterdam 31
Chicago 31
Rome 31
Warsaw 31
Kunming 30
Atlanta 29
Nuremberg 29
Tashkent 29
Jinan 27
Redwood City 27
Denver 25
Phoenix 25
San Francisco 24
Turku 23
Changsha 22
Manchester 22
Johannesburg 21
Curitiba 20
Dong Ket 20
Porto Alegre 20
Toronto 20
Boston 19
Haiphong 19
Mexico City 19
Poplar 19
Barnet 18
Brasília 18
Campinas 18
Lahore 18
Milan 18
Shanghai 18
Dhaka 17
Hyderabad 17
Quito 17
Washington 17
Zhengzhou 17
Kuala Lumpur 16
Trinitapoli 16
Totale 16.648
Nome #
Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy 265
Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity 232
Long-term exposure of pancreatic β-cells to palmitate results in SREBP-1C-dependent decreases in GLP-1 receptor signaling via CREB and AKT and insulin secretory response 224
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 212
Abnormalities of insulin-like growth factor-l Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis 209
Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy 209
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases 206
Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy 202
GLP-1: a new approach for type 2 diabetes therapy 198
PKB/Akt and MAPK/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia 196
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 192
Diabetes and cancer: pathophysiological fundamentals of a 'dangerous affair' 182
Insulin and Insulin Receptors in Adipose Tissue Development 182
Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysin63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy 178
Clinical view on the need to develop new anti-diabetic drugs 177
The p66Shc Protein Controls Redox Signaling and Oxidation-Dependent DNA Damage in Human Liver Cells 176
Irisin Increases the Expression of Anorexigenic and Neurotrophic Genes in Mouse Brain 174
GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells 173
The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells 168
GLP-1 Receptor Agonist Added to Insulin versus Basal-plus or Basal-bolus Insulin Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis 168
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 164
Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway. 160
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. 154
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 154
Interventional therapy in diabetic foot: Risk factors, clinical events and prognosis at one year follow-up (a study of 103 cases) 153
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. 152
Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane 148
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 147
Effects of CPAP on testosterone levels in patients with obstructive sleep apnea: a meta-analysis study 147
Abnormalities of cardiac insulin signaling in experimental diabetes 146
The myokine irisin is released in response to saturated fatty acids and promotes pancreatic β-cell survival and insulin secretion 145
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis 144
Relationship between risk factors and mortality in type 1 diabetic patients in europe: The eurodiab prospective complications study (PCS) 143
Effects of Extra Virgin Olive Oil Polyphenols on Pancreatic Beta-Cell Function and Survival 142
Biological specificity of visceral adipose tissue and therapeutic intervention 141
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. 141
Association between physical activity estimated by the International physical activity questionnaire and UKPDS cardiovascular risk in score type 2 diabetes. 141
Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis 141
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. 138
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: A cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 138
Chronic palmitate excess results in reduced exendin-4 action and signalling via CREB and Akt in pancreatic beta cells 138
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 137
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method 137
Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy 137
Differences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and visceral adipose tissue in humans. 136
Glucagon-Like Peptide-1 Counteracts Oxidative Stress-Dependent Apoptosis of Human Cardiac Progenitor Cells by Inhibiting the Activation of the c-Jun N-terminal Protein Kinase Signaling Pathway 136
Adipose tissue precursor cells 136
Ubc9 regulation of glucose transport in 3T3-L1 adipocytes is differentiation-dependent. 135
Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia. 135
Irisin Enhances Pancreatic Beta-Cell Survival and Insulin Secretion and Can Mediate the Metabolic Cross Talk between the Skeletal Muscle and Endocrine Pancreas 134
Comparison of Distinct GLP-1 Receptor Agonists in Palmitate-induced Incretin Resistance of Pancreatic Beta Cells 134
Dysmetabolic adipose tissue in obesity: morphological and functional characteristics of adipose stem cells and mature adipocytes in healthy and unhealthy obese subjects 134
Decreased IRS phosphorylation and altered Erk activation in osteoblasts from osteoporotic subjects. 133
Abnormalities in IGF-I signalling and impaired cell proliferation in osteoblasts from patients with osteoporosis. 133
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. 133
TNFα Signals via p66(Shc) to Induce E-Selectin, Promote Leukocyte Transmigration and Enhance Permeability in Human Endothelial Cells 131
HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. 131
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies 131
Apoptotic and survival signals triggered by high glucose in human mesangial cells. 130
Correction of Intermittent Hypoxia with CPAP Improves Cardiometabolic Abnormalities, and Systemic and Adipose Tissue Inflammation in Obese Subjects with Obstructive Sleep Apnea. 130
The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis 130
Carriers of the TCF7L2 rs7903146 variant with GMD have an increate risk of developing impaired glucose regulation after pregnancy. 128
Different gene expression in human heart tissue and progenitor cells from control and diabetic subjects: relevance to the pathogenesis of human diabetic cardiomyopathy 128
Associated hormonal declines in aging: DHEAS 127
Effects of irisin on leptin and ghrelin secretion and expression of the major appetite regulators in mouse brain 127
The SUMO-conjugating enzyme Ubc9 is essential for insulin-responsive glucose transport in adipocytes. 125
Pathophysiology of type 2 diabetes: rationale for different oral antidiabetic treatment strategies 125
Irisin improves the secretory defects of pancreatic islets from type 2 diabetic subjects 125
Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts 124
Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling 124
Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection 124
Exploiting the pleiotropic actions of GLP-1 for the management of type 2 diabetes mellitus and its complications. 123
Cross-Talk between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity 122
Functional loss of pancreatic islets in type 2 diabetes: How can we halt it? 122
The myokine irisin is released in response to saturated fatty acids and enhances pancreatic beta cell survival and insulin secretion 121
The p66Shc protein mediates saturated fatty acid-induced insulin resistance in pancreatic beta cells 121
P2 purinergic agonists and 12-O-tetradecanoylphorbol-13-acetate, as well as protein kinase A activators, stimulate thyroglobulin secretion in FRTL-5 cells 120
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study. 119
Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo 118
58th EASD Annual Meeting of the European Association for the Study of Diabetes : Stockholm, Sweden, 19 - 23 September 2022 117
A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial 116
Involvement of Actin Cytoskeleton in Free Fatty Acid-induced Beta-Cell Death. 116
Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling 115
Insulin signaling in human visceral and subcutaneous adipose tissue in vivo 115
PPAR-gamma agonisti nella terapia del diabete mellito e di altre malattie endocrino-metaboliche 113
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 113
Role of p66Shc in cytokine-mediated leukocyte recruitment by endothelial cells. 112
Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes 112
The p66Shc Protein Mediates Insulin Resistance and Secretory Dysfunction in Pancreatic β-Cells Under Lipotoxic Conditions 111
Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study. 111
Involvement of actin cytoskeleton in free fatty acid-induced beta cell death 110
Human adipose tissue precursor cells: a new factor linking regulation of fat mass to obesity and type 2 diabetes? 109
The Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor 109
Effects of extra virgin olive oil polyphenols on beta-cell function and survival 109
Requirement of the SUMO-conjugating enzyme Ubc9 for insulin-responsive glucose transport in adipocytes. 108
Key role of the p66Shc protein in the regulation of the glucose transport system in skeletal muscle cells. 108
TNF alpha impairs insulin signaling in pancreatic beta-cells through JNK-dependent serine phosphorylation of IRS-2. 106
Role of the p66Shc isoform in insulin-like growth factor I receptor signaling through MEK/Erk and regulation of actin cytoskeleton in rat myoblasts 106
Impact of Dysfunctional Adipose Tissue Depots on the Cardiovascular System 105
p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress 105
Totale 14.222
Categoria #
all - tutte 101.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021456 0 0 0 0 0 0 0 0 0 239 105 112
2021/20221.573 51 215 15 99 62 86 56 88 108 98 280 415
2022/20232.588 326 293 147 233 318 396 34 287 445 17 55 37
2023/2024935 77 184 54 72 111 236 14 53 14 32 4 84
2024/20253.868 58 67 307 134 117 377 354 401 203 187 572 1.091
2025/20268.126 1.261 437 490 1.063 1.077 569 1.064 281 959 925 0 0
Totale 25.206